Monocarbinol terminated polydimethylsiloxane, asymmetric, 80-90cSt, 97%, 100g

1-(4,6-Dimethyl-pyrimidin-2-yl)-pyrrolidin-3-ol, 500mg

2-Methyl-2-(piperidin-1-yl)propanoic acid, 98%, 1g

methyl 2-(2-imino-5,7-dimethylbenzo[d]thiazol-3(2H)-yl)acetate hydrobromide, 95.0%, 500mg

1-Bromo-4-ethoxy-2-fluorobenzene, 95.0%, 1g

Piperidine, PEPTIPURE®, min. 99.5%, for peptide synthesis, 500 ml, glass packaging

3-(Phenylmethyl)-2-[(1E)-2-(3-pyridinyl)ethenyl]-4(3H)-quinazolinone, 98%, 5mg

3-Formyl-4-methoxyphenylboronic acid, 98.0%, 25g

2-Ethylmorpholine, 95.0%, 5g

4-HYDROXY-3,3-DIMETHYL-1-[(1R)-1-PHENYLETHYL]PYRROLIDIN-2-ONE, 95.0%, 1g

1-(4-Fluorophenyl)biguanide hydrochloride, 97.0%, 100mg

Diethyl phenylphosphonite, 95.0%, 100g

7-Nitro-benzo[b]thiophene-2-carboxylic acid, 95.0%, 1g